AXT Rides China AI Optics Wave for a Second Day, but Can the Rally Survive Its Own Hype

Shares of AXT Inc. surged 6.9% to $52.21 on Tuesday, extending a two-session rally that has recouped most of last week's sharp selloff from a $57.57 high, as investors bet that China's newly announced domestic AI optics standard will funnel orders directly to the company's substrate business. AXT Rides China AI Optics Wave for a Second Day, but Can the Rally Survive Its Own Hype

Shares of AXT Inc. jumped 6.9% to $52.21 Tuesday, extending a two-day bounce from last week's dip into the mid-$40s as Wall Street enthusiasm around China's new AI optics standard continued to ripple through the stock. China launched its first domestic near-packaged optics multi-source agreement for artificial intelligence interconnects, a move that Wedbush Securities called "directly positive" for AXT. The broader chip sector's rebound added fuel, but the question for shareholders is whether the company's fundamentals can keep pace with a stock that has already risen roughly 4,500% from its 2025 lows.

• China's New Optics Standard Hands AXT a Permit-Free Growth Lane. AXT's subsidiary Tongmei manufactures inside China, meaning no export permit is required for domestic shipments — a critical advantage as Beijing accelerates its AI supply chain.

In Q1 2026, indium phosphide revenues hit $13.6 million, with China's laser-related portion more than doubling quarter-over-quarter — and management expects it to double again in Q2. A new domestic standard that formalizes demand for these components could lock in years of orders that sidestep the export-permit bottleneck.

• A $3 Billion Valuation Built on $96 Million in Revenue. AXT currently trades at a forward price-to-earnings ratio of roughly 147, with trailing revenue of $95.9 million, a –14.7% profit margin, and –$25.3 million in free cash flow.

The company raised $632.5 million in equity to double indium phosphide capacity in both 2026 and 2027 , but Q1 still showed a net loss of $1.6 million despite revenue climbing 39% year-over-year to $26.9 million. Investors are paying up for a future that hasn't yet arrived.

• Analyst Targets Range From Skeptical to Euphoric. Wedbush recently raised its price target to $93 while maintaining an Outperform rating.

Northland is even more bullish at $125.

Yet the lowest Street target sits at just $21 , reflecting deep disagreement over whether AI-driven substrate demand can transform a money-losing niche supplier into a sustainably profitable business.

• Insider Sales and Wild Swings Signal Caution. Director Jesse Chen sold shares worth roughly $2.75 million in mid-June while the stock was elevated.

Implied volatility sits at ~154, nearly five times the market average , meaning the stock routinely swings double digits in a single session. For anyone buying here, the China optics story is real — but the price already assumes a lot goes right.